Clinical Trials in Pittsburgh

Showing 18501-18520 of 21,047 trials

Mechanisms of Adaptation in Human Short Bowel Syndrome

NCT00248573

This is an observational, natural history trial of mechanisms of gut adaptation in adult short bowel syndrome (SBS). Patients with SBS (\< 200 cm small bowel ± colon) will be studied initially 2-9 months after the last small bowel resection and again exactly 6 months after the initial study. GCRC-studies will examine intestinal nutrient absorption, gut barrier functions and gut mucosal biopsy specimens for markers of nutrient transport and cell proliferation and apoptosis.

Short Bowel Syndrome

Emory University32 participantsStarted Oct 2004

Cleveland, Ohio, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

NCT00679588

The primary objective is to compare the efficacy and safety of once daily (q.d.) subcutaneous (s.c.) injections of Semuloparin sodium (AVE5026) with q.d. s.c. injections of Enoxaparin for the prevention of Venous Thromboembolic Events (VTE) in patients undergoing major abdominal surgery. The secondary objectives are to evaluate the safety of Semuloparin sodium (AVE5026) and to document Semuloparin sodium (AVE5026) exposure in this population.

Venous Thromboembolism

Sanofi4,413 participantsStarted Apr 2008

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +267 more locations

Mechanisms of Adaptation in Human Short Bowel Syndrome

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

Find Trials by Condition in Pittsburgh

Interventional Management of Stroke (IMS) III Trial

Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel

A Study of Influenza Virus Vaccines in Children and Adults

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent

Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT)

Beta Alethine in Treating Patients With Myeloma

Assessment of Head Injury in the Emergency Department Using BrainScope® Ahead® Technology

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2)

Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

VI-1121 for the Treatment Alzheimer's Disease

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

A Study to Evaluate Insulin in the Blood After Inhalation of a Dry Powder Insulin Formulation (Called Technosphere®/Insulin) in Non-diabetic Patients With & Without Chronic Obstructive Pulmonary Disease (COPD)